A carregar...
A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
GnRH antagonist and GnRH agonist are widely used as androgen deprivation therapy for metastatic prostate cancer. A previous report demonstrated that patients with PSA levels of >20 ng/mL using GnRH antagonists showed favorable outcomes in comparison to those using GnRH agonists. An 82-year old ma...
Na minha lista:
| Publicado no: | Case Rep Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787414/ https://ncbi.nlm.nih.gov/pubmed/31607884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000502859 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|